drugset / Trial / NCT00439140
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the safety and efficacy of botulinum toxin Type A for the treatment of urinary incontinence overactive bladder in patients with a spinal cord injury or multiple sclerosis.
Timeline
- Start
- 2007-06
- Primary completion
- 2012-12
- Completion
- 2012-12
Outcome
Outcome not reported
Stopped: “In agreement with FDA the study was terminated based on data available.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 300 iu | Other |